Speech-Language Pathologists in Wakefield, NE Accepting Medicare

21 Speech-Language Pathologists found. Showing 1 - 20

Mrs. Carol Mcguire Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061    Fax: 402-287-2065

Mrs. Carol Olson-conrad Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Nancy Dean, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Mrs. Jessica Jill Fischer, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Rebecca Ridgway Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Jenna Mae Mcafee, M.A. SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Megan Rose Gubbels, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Mrs. Janette Deck, M. A. SLP CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th Street, Unit 1 Educationl Service, Wakefield, NE 68784 Phone: 402-287-2061

Mrs. Anne Marie Ronhovde, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 802 Highland St, Wakefield, NE 68784 Phone: 402-287-2012

Wendy Consoli, MA,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Ashley Tapper Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 712-229-0682

Desiree Rose, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Wendy Ellen Sudbeck Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Miss Hannah Davis, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Adrienne Timm, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Catherine Schroeder, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Kimberley Kay Halle Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Molly Stenger Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Andrea Janzen Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061

Pamela Kay Barnes, MHS/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 10th St, Wakefield, NE 68784 Phone: 402-287-2061    Fax: 402-287-2065

News Archive

Bayer's regorafenib granted FDA Fast Track designation for treatment of GIST

Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.

Scientists identify new biomarker to detect subclinical atherosclerosis

Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Instituto de Investigación Sanitaria-Fundación Jiménez Díaz in Madrid have demonstrated that a proteins present in early atheroma plaques-accumulations of cholesterol in the wall of arteries-could be used as a biomarker to detect atherosclerosis in the subclinical phase, before the appearance of symptoms.

Mayo Clinic and collaborators to test new ways to provide specialized TBI care

For people who are hospitalized for traumatic brain injury, recovery may involve physical and cognitive problems that linger for years. The road back to health can be even more arduous for those who live in remote rural areas and don't have access to brain rehabilitation specialists. Mayo Clinic and collaborators, have received a $2.2 million federal grant to test new ways to provide specialized TBI care, with a focus on reaching rural areas and underserved urban populations.

Insilico Medicine presents experimentally validated model for drug discovery at NeurIPS 2019

Insilico Medicine, a biotechnology company developing an end-to-end drug discovery pipeline utilizing next-generation artificial intelligence, is proud to present its paper "A Prior of a Googol Gaussians: a Tensor Ring Induced Prior for Generative Models" at the 33rd Conference on Neural Information Processing Systems (NeurIPS).

Read more Medical News

› Verified 7 days ago

• 1(current)
• 2